P henobarbital-Dilantin treatment of the intrauterine patient.
D004790:Enzyme Induction; D004827:Epilepsy / Q000150:complications; D004899:Erythroblastosis, Fetal / Q000188:drug therapy; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control; D007567:Jaundice, Neonatal / Q000517:prevention & control*; D008099:Liver / Q000201:enzymology*; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications
D010672:Phenytoin; D010634:Phenobarbital
Phenobarbital-Dilantin treatment of the intrauterine patient.